|
CN110973432A
|
|
Ginseng solid beverage and preparation method thereof
|
|
CN110974812A
|
|
GPR35 receptor new agonist and application thereof
|
|
CN110974874A
|
|
Method for preparing flavone and saponin components in spina date seed extract
|
|
CN110974858A
|
|
Refined American ginseng total saponin component and method for purifying and preparing American ginseng total saponin
|
|
CN110981786A
|
|
2-arylvinyl-cyclic amine derivative and preparation method and application thereof
|
|
CN110981787A
|
|
2- (2, 2-diaryl vinyl) -quaternary ammonium salt type cyclic amine derivative and preparation method thereof
|
|
CN111349608A
|
|
Cell screening model of unmarked histamine receptor H2
|
|
CN111349609A
|
|
Cell screening model of unmarked histamine receptor H3
|
|
CN111349612A
|
|
Cell screening model of unmarked opioid receptor NOP
|
|
CN111349611A
|
|
Cell screening model of unmarked Kappa receptor
|
|
CN111349610A
|
|
Cell screening model of unmarked Delta receptor
|
|
CN111349613A
|
|
Cell screening model of unmarked muscarinic receptor M4
|
|
CN111349607A
|
|
Cell screening model of unmarked bombesin receptor BB3
|
|
CN111329905A
|
|
Total alkaloid component extracted from coptis chinensis and refining method thereof
|
|
CN111328893A
|
|
Dry powder extracted from black tea and refining process thereof
|
|
CN110974873A
|
|
Spina date seed oil inclusion compound and preparation method and application thereof
|
|
CN110974857A
|
|
Refined panax notoginseng saponins and purification preparation method for extracting panax notoginseng saponins
|
|
CN111012831A
|
|
Wild jujube kernel oil microcapsule powder and preparation method and application thereof
|
|
CN110898095A
|
|
Honeysuckle refined product and preparation method and application thereof
|
|
CN110903191A
|
|
Method for extracting chlorogenic acid from honeysuckle
|
